Ophthalmology News

Ophthal

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Bhat P et al. - The mean follow-up time was 15.3 months. The mean intravitreal injections administered were 2.7. All patients showed a reduction in the size of the CNV with improvement in BCVA in 60% of cases at the last follow-up. Intravitreal bevacizumab may provide an additional strategy in the management of inflammatory CNV.


Today in Clinical Pharmacology...keeping you current

Effect of oral azithromycin in the treatment of chlamydial conjunctivitis
Eye, 11/09/09

Central Corneal Thickness During Treatment With Travoprost 0.004% in Glaucoma Patients
Journal of Ocular Pharmacology and Therapeutics, 11/02/09

Retinal function in patients treated with tamoxifen
Documenta Ophthalmologica, 11/16/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address